Stock Screener App

Frei -

Installieren

6.62

2.16% 0.14

after-market

Handel nachbörslich: 6.62

Diamedica Therapeutics Inc (DMAC)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Diamedica Therapeutics Inc-Aktie (DMAC)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Research and Development	10.56% 6.437	5.822	5.656	6.47	4.983
Operating Income/Loss	12.81% -9.033	-8.007	-8.144	-8.419	-6.883
Nonoperating Income/Loss	33.44% 0.419	0.314	0.443	-	-
Income/Loss From Continuing Operations Before Tax	11.97% -8.614	-7.693	-7.701	-7.891	-6.267
Income Tax Expense/Benefit	0.00% 0.006	0.006	0.006	0.009	0.007
Income/Loss From Continuing Operations After Tax	11.96% -8.62	-7.699	-7.707	-7.90	-6.274
Net Income/Loss	11.96% -8.62	-7.699	-7.707	-7.90	-6.274
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	15.53% 49.63	42.96	42.84	0.8005	42.75
Basic Earnings Per Share	5.56% -0.17	-0.18	-0.18	-0.18	-0.15
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

MRNA

$48.77

0.87%

ROIV

$27.88

1.59%

RPRX

$47.32

2.57%

BNTX

$91.28

0.11%

ONC

$302.49

2.67%

INSM

$163.81

0.85%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters